S Korec
Impact in
- Immunology top 5%
- Complement system in diseases
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
Papers in
-
- Complement system in diseases 5
- Immune Cell Function and Interaction 2
- Oncology 7
- Neutropenia and Cancer Infections 5
- Cancer Treatment and Pharmacology 1
- Co-authors
- Margareta Klein (2 shared papers)Tina Haliotis (2 shared papers)John Roder (2 shared papers)Paul Katz (2 shared papers)Philip S. Schein (2 shared papers)Paul V. Woolley (2 shared papers)James R. Jett (1 shared paper)Anthony S. Fauci (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Cancer (1 paper)Breast Cancer Research and Treatment (1 paper)The Journal of Experimental Medicine (1 paper)Nature (1 paper)
- Partner nations
- United StatesCanadaSlovakia
In The Last Decade
S Korec
14 papers receiving 801 citations
Peers
Comparison fields: 5 of 76
- Immunology 512
- Nephrology 160
- Hematology 229
- Transplantation 45
- Genetics 86
Countries citing papers authored by S Korec
This map shows the geographic impact of S Korec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Korec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Korec more than expected).
Fields of papers citing papers by S Korec
This network shows the impact of papers produced by S Korec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Korec. The network helps show where S Korec may publish in the future.
Co-authors
The 25 scholars most cited alongside S Korec, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 223 | |
| 2 | 1980 | 211 | |
| 3 | 2004 | 121 | |
| 4 | 1980 | 87 | |
| 5 | 1993 | 83 | |
| 6 | 1986 | 60 | |
| 7 | 1980 | 42 | |
| 8 | 1988 | 10 | |
| 9 | Clinical experiences with extracorporeal immunoperfusion of plasma from cancer patients. | 1984 | 8 |
| 10 | 1981 | 6 | |
| 11 | Change in the proportion of T and B lymphocytes in human malignant neoplasia in relation to the clinical stage. | 1975 | 4 |
| 12 | 1996 | 3 | |
| 13 | 1992 | 3 | |
| 14 | Ceftriaxone versus ceftazidime plus aminoglycoside therapy for infections in patients with neutropenia after cytotoxic chemotherapy. Short communication. | 1993 | 1 |
About S Korec
S Korec is a scholar working on Immunology, Oncology, Hematology, Physiology and Genetics, having authored 14 papers that have together received 862 indexed citations. Recurring topics across this work include Complement system in diseases (5 papers), Neutropenia and Cancer Infections (5 papers), Blood groups and transfusion (3 papers), Erythrocyte Function and Pathophysiology (3 papers), Blood disorders and treatments (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Immune Cell Function and Interaction (2 papers) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Immunology (512 citations), Nephrology (160 citations), Hematology (229 citations), Transplantation (45 citations) and Genetics (86 citations). S Korec has collaborated with scholars based in United States, Canada and Slovakia. Frequent co-authors include Margareta Klein, Tina Haliotis, John Roder, Paul Katz, Philip S. Schein, Paul V. Woolley, James R. Jett, Anthony S. Fauci, John R. Ortaldo and Bradley A. Erickson. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Breast Cancer Research and Treatment, The Journal of Experimental Medicine and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.